Answers are grounded in this paper and cite their sources.
Palladium-catalyzed cross-couplings are frequently limited by off-cycle deactivation pathways, particularly phosphine deligation followed by aggregation of Pd(0) to catalytically inactive palladium black. We report an “on-cycle enforcement” strategy that employs a cooperative, nonalloyed trimetallic assembly─Pd(0), Cu(I), and Mn(III)─confined within PS-750-M/HPMC micelles in water. In this architecture, Pd mediates the canonical oxidative addition and reductive elimination steps, Cu(I) accelerates transmetalation via a Cu-nucleophile intermediate, and Mn(II/III) serves as a redox buffer that likely continuously reoxidizes off-cycle Pd(0) to micelle-soluble Pd(II), followed by its religation and reduction, thereby preventing Pd black formation. Spectroscopic analysis─transmission electron microscopy, scanning transmission electron microscopy–high-angle annular dark-field imaging, energy-dispersive X-ray spectroscopy, X-ray photoelectron spectroscopy, and X-ray absorption spectroscopy─reveals that the three metals remain spatially separated in the assembly yet electronically complementary within a phosphorus-rich matrix, enabling persistent catalytic activity. The resulting platform supports rapid, selective C–C couplings at 45 °C with broad substrate compatibility, including heteroarenes and terminal olefin─containing partners, without olefin interference. The catalyst displays exceptional longevity, minimal metal leaching (<1 ppm), and robust scalability, with multicycle reactions and gram-scale processes proceeding efficiently even after extended catalyst storage. These findings establish redox-buffered, compartmentalized trimetallic assemblies as a general solution to enforcing on-cycle Pd catalysis in water.
No takes yet. Share an insight, caveat, or question.
Sharma et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: